Clinical Trial Update: The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two aspirin dosing strategies in obese women at high risk for preeclampsia was terminated; results were posted on 2024-04-29.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Ohio State University | Conditions: Preeclampsia | Phase 4 | Status: TERMINATED | Results posted: 2024-04-29